The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI) Predicts Survival and Tolerance of Ibrutinib Therapy in Patients with CLL: A Multicenter Retrospective Cohort Study

被引：0
|
作者：
Gordon, Max J.
Kaempf, Andy
Sitlinger, Andrea
Salous, Tareq
Alqahtani, Hamood
Churnetski, Michael C.
Wisniewski, Paul
Rivera, Xavier Issac
Patel, Krish
Persky, Daniel O.
Cohen, Jonathon B.
Choi, Michael Y.
Hill, Brian T.
Shadman, Mazyar
Stephens, Deborah M.
Brander, Danielle M.
Park, Byung
Danilov, Alexey
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-136808
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Novel Comorbidity Score Derived from a Large Multicenter Retrospective Cohort Study of Patients Treated with Ibrutinib and/or Chemo-Immunotherapy (CIT)
    Gordon, Max J.
    Kaempf, Andy
    Sitlinger, Andrea
    Salous, Tareq
    Alqahtani, Hamood
    Churnetski, Michael C.
    Wisniewski, Paul
    Rivera, Xavier Issac
    Patel, Krish
    Persky, Daniel O.
    Cohen, Jonathon B.
    Choi, Michael Y.
    Hill, Brian T.
    Shadman, Mazyar
    Stephens, Deborah M.
    Brander, Danielle M.
    Park, Byung
    Danilov, Alexey
    BLOOD, 2019, 134
  • [2] The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model
    Gordon, Max J.
    Kaempf, Andy
    Sitlinger, Andrea
    Shouse, Geoffrey
    Mei, Matthew
    Brander, Danielle M.
    Salous, Tareq
    Hill, Brian T.
    Alqahtani, Hamood
    Choi, Michael
    Churnetski, Michael C.
    Cohen, Jonathon B.
    Stephens, Deborah M.
    Siddiqi, Tanya
    Rivera, Xavier
    Persky, Daniel
    Wisniewski, Paul
    Patel, Krish
    Shadman, Mazyar
    Park, Byung
    Danilov, Alexey V.
    CLINICAL CANCER RESEARCH, 2021, 27 (17) : 4814 - 4824
  • [3] Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI), a Novel Comorbidity Measure, Predicts Outcomes in the Context of Targeted Agents and in a Large National Registry
    Gordon, Max J.
    Kaempf, Andy
    Rotbain, Emelie
    Sitlinger, Andrea
    Shouse, Geoffrey
    Mei, Matthew
    Brander, Danielle M.
    Salous, Tareq
    Hill, Brian T.
    Choi, Michael
    Cohen, Jonathon B.
    Stephens, Deborah M.
    Persky, Dan O.
    Patel, Krish
    Shadman, Mazyar
    Park, Byung
    Niemann, Carsten Utoft
    Danilov, Alexey V.
    BLOOD, 2021, 138
  • [4] Pharmacokinetics (PK) of ibrutinib in patients with chronic lymphocytic leukemia (CLL)
    Sukbuntherng, Juthamas
    Jejurkar, Purvi
    Chan, Stephen
    Tran, Anh L.
    Moussa, Davina
    James, Danelle Frances
    Loury, David
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL)
    Nicholas Wright
    Ensi Voshtina
    Gemlyn George
    Arun Singavi
    Joshua Field
    International Journal of Hematology, 2019, 110 : 751 - 755
  • [6] Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL)
    Wright, Nicholas
    Voshtina, Ensi
    George, Gemlyn
    Singavi, Arun
    Field, Joshua
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (06) : 751 - 755
  • [7] Comorbidity and cause of death in patients with chronic lymphocytic leukemia (CLL)
    Strati, Paolo
    Chaffe, Kari
    Achenbach, Sara
    Call, Timothy
    Kay, Neil
    Cerhan, James
    Slager, Susan
    Shanafelt, Tait
    CANCER RESEARCH, 2015, 75
  • [8] Chronic lymphocytic leukemia (CLL) patients at a VA medical center: Comorbidity and survival.
    Soriano, L.
    Srinivas, S.
    Tufail, M.
    Kim, K.
    Paulin, R.
    Chang, V. T.
    Kasimis, B.
    Gonzalez, M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL): An Analysis of a Large Cohort of Patients Treated in Routine Clinical Practice
    Parikh, Sameer A.
    Chaffee, Kari Rabe
    Call, Timothy G.
    Ding, Wei
    Leis, Jose F.
    Chanan-Khan, Asher
    Bowen, Deborah A.
    Conte, Michael
    Van Dyke, Daniel L.
    Hanson, Curtis A.
    Schwager, Susan M.
    Slager, Susan L.
    Kay, Neil E.
    Shanafelt, Tait D.
    BLOOD, 2015, 126 (23)
  • [10] Phase Ib Study of Ianalumab (VAY736) and Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL) on Ibrutinib Therapy
    Rogers, Kerry A.
    Flinn, Ian W.
    McGarry, Carolyn
    Gou, Liangke Connie
    Hassounah, Nadia
    Woo, Janghee
    Byrd, John C.
    BLOOD, 2020, 136
12345